|
1
|
Optimization of halopemide for phospholipase D2 inhibition.
|
Bioorg Med Chem Lett
|
2007
|
1.58
|
|
2
|
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV).
|
Proc Natl Acad Sci U S A
|
2011
|
1.08
|
|
3
|
Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens.
|
J Med Chem
|
2014
|
0.98
|
|
4
|
Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.
|
Biochemistry
|
2010
|
0.88
|
|
5
|
Atomic-scale characterization of conformational changes in the preQ₁ riboswitch aptamer upon ligand binding.
|
J Mol Graph Model
|
2011
|
0.84
|
|
6
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|
|
7
|
1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists.
|
J Med Chem
|
2010
|
0.78
|
|
8
|
Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.
|
Sci Rep
|
2015
|
0.75
|
|
9
|
Design, Synthesis and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
|
J Med Chem
|
2017
|
0.75
|